Zhang Ailun, Gu Guorong, Zhu Jing, Shao Wenqi, Yang Jing, Pan Baishen, Wang Beili, Yao Chenling, Guo Wei
Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Clin Chem Lab Med. 2025 Apr 17;63(7):1443-1452. doi: 10.1515/cclm-2024-1118. Print 2025 Jun 26.
We aimed to evaluate sex-specific 0-h high-sensitivity cardiac troponin T (hs-cTnT) thresholds for risk stratification in patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI).
This retrospective study investigated a derivation cohort of 6,691 (44.4 % female and aged 65 (57-72) years) and a validation cohort of 6,589 (48.4 % female and aged 63 (50-71) years) patients with suspected NSTEMI who visited the emergency department. Uniform and sex-specific thresholds were derived and validated, and their performances were compared.
In the derivation cohort, 11.3 % of males and 5.4 % of females were diagnosed with adjudicated NSTEMI. As male-specific thresholds, 0-h hs-cTnT <10 ng/L ruled out 30.1 % of patients with an NPV of 99.6 % [95 % CI (99.0-99.9 %)], and 0-h hs-cTnT ≥65 ng/L ruled in 12.3 % of patients with a PPV of 70.5 % [95 % CI (66.0-74.6 %)]. As female-specific thresholds, 0-h hs-cTnT <9 ng/L ruled out 39.2 % of patients with an NPV of 99.9 % [95 % CI (99.4-100.0 %)], and 0-h hs-cTnT ≥45 ng/L ruled in 6.7 % of patients with a PPV of 71.7 % [95 % CI (64.8-77.8 %)]. The validation cohort showed similar results. Sex-specific and uniform thresholds did not significantly affect rule-in performance, whereas sex-specific thresholds increased female sensitivity by 1 % (99.7 vs. 98.7 %). Patient follow-up did not change when sex-specific thresholds were applied.
Sex-specific 0-h hs-cTnT thresholds could slightly improve the safety in ruling out NSTEMI in females, but their role in terms of efficiency, rule-in performance and prognosis was similar to that of uniform thresholds.
我们旨在评估针对疑似非ST段抬高型心肌梗死(NSTEMI)患者进行危险分层的性别特异性0小时高敏肌钙蛋白T(hs-cTnT)阈值。
这项回顾性研究调查了一个由6691名(44.4%为女性,年龄65(57 - 72)岁)患者组成的推导队列和一个由6589名(48.4%为女性,年龄63(50 - 71)岁)疑似NSTEMI且就诊于急诊科的患者组成的验证队列。得出并验证了统一的和性别特异性的阈值,并比较了它们的性能。
在推导队列中,11.3%的男性和5.4%的女性被诊断为经判定的NSTEMI。作为男性特异性阈值,0小时hs-cTnT <10 ng/L排除了30.1%的患者,阴性预测值为99.6% [95%可信区间(99.0 - 99.9%)],0小时hs-cTnT≥65 ng/L纳入了12.3%的患者,阳性预测值为70.5% [95%可信区间(66.0 - 74.6%)]。作为女性特异性阈值,0小时hs-cTnT <9 ng/L排除了39.2%的患者,阴性预测值为99.9% [95%可信区间(99.4 - 100.0%)],0小时hs-cTnT≥45 ng/L纳入了6.7%的患者,阳性预测值为71.7% [95%可信区间(64.8 - 77.8%)]。验证队列显示了相似的结果。性别特异性和统一阈值对纳入性能没有显著影响,而性别特异性阈值使女性的敏感性提高了1%(99.7%对98.7%)。应用性别特异性阈值时患者随访情况未改变。
性别特异性的0小时hs-cTnT阈值可在排除女性NSTEMI方面略微提高安全性,但其在效率、纳入性能和预后方面的作用与统一阈值相似。